S&P 500   3,166.94 (-0.05%)
DOW   28,118.49 (-0.05%)
QQQ   207.14 (+0.31%)
FB   194.86 (-0.96%)
MSFT   154.81 (+1.02%)
AMZN   1,763.01 (+0.15%)
CGC   21.59 (+2.18%)
NVDA   224.58 (+0.23%)
MU   51.42 (+0.88%)
BABA   205.07 (+0.28%)
GE   11.41 (-0.26%)
T   38.09 (-0.68%)
ACB   2.66 (+1.92%)
F   9.22 (-1.18%)
BAC   34.56 (-0.35%)
GILD   66.10 (-2.26%)
DIS   147.01 (-0.51%)
S&P 500   3,166.94 (-0.05%)
DOW   28,118.49 (-0.05%)
QQQ   207.14 (+0.31%)
FB   194.86 (-0.96%)
MSFT   154.81 (+1.02%)
AMZN   1,763.01 (+0.15%)
CGC   21.59 (+2.18%)
NVDA   224.58 (+0.23%)
MU   51.42 (+0.88%)
BABA   205.07 (+0.28%)
GE   11.41 (-0.26%)
T   38.09 (-0.68%)
ACB   2.66 (+1.92%)
F   9.22 (-1.18%)
BAC   34.56 (-0.35%)
GILD   66.10 (-2.26%)
DIS   147.01 (-0.51%)
S&P 500   3,166.94 (-0.05%)
DOW   28,118.49 (-0.05%)
QQQ   207.14 (+0.31%)
FB   194.86 (-0.96%)
MSFT   154.81 (+1.02%)
AMZN   1,763.01 (+0.15%)
CGC   21.59 (+2.18%)
NVDA   224.58 (+0.23%)
MU   51.42 (+0.88%)
BABA   205.07 (+0.28%)
GE   11.41 (-0.26%)
T   38.09 (-0.68%)
ACB   2.66 (+1.92%)
F   9.22 (-1.18%)
BAC   34.56 (-0.35%)
GILD   66.10 (-2.26%)
DIS   147.01 (-0.51%)
S&P 500   3,166.94 (-0.05%)
DOW   28,118.49 (-0.05%)
QQQ   207.14 (+0.31%)
FB   194.86 (-0.96%)
MSFT   154.81 (+1.02%)
AMZN   1,763.01 (+0.15%)
CGC   21.59 (+2.18%)
NVDA   224.58 (+0.23%)
MU   51.42 (+0.88%)
BABA   205.07 (+0.28%)
GE   11.41 (-0.26%)
T   38.09 (-0.68%)
ACB   2.66 (+1.92%)
F   9.22 (-1.18%)
BAC   34.56 (-0.35%)
GILD   66.10 (-2.26%)
DIS   147.01 (-0.51%)
Log in

NASDAQ:AVDR - Avedro Stock Price, Forecast & News

$22.99
0.00 (0.00 %)
(As of 12/6/2019)
Today's Range
$22.99
Now: $22.99
$22.99
50-Day Range
$20.99
MA: $23.10
$24.05
52-Week Range
$10.75
Now: $22.99
$27.51
VolumeN/A
Average Volume89,666 shs
Market Capitalization$402.78 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products through a direct sales force in the United States and through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AVDR
CUSIPN/A
CIKN/A
Phone781-768-3400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.67 million
Book Value$2.52 per share

Profitability

Net Income$-25,120,000.00

Miscellaneous

Employees122
Market Cap$402.78 million
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive AVDR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVDR and its competitors with MarketBeat's FREE daily newsletter.


Avedro (NASDAQ:AVDR) Frequently Asked Questions

What is Avedro's stock symbol?

Avedro trades on the NASDAQ under the ticker symbol "AVDR."

How were Avedro's earnings last quarter?

Avedro Inc (NASDAQ:AVDR) released its earnings results on Wednesday, November, 6th. The company reported ($0.52) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.50) by $0.02. The firm had revenue of $11.05 million for the quarter, compared to analysts' expectations of $9.96 million. Avedro had a negative return on equity of 162.76% and a negative net margin of 81.59%. View Avedro's Earnings History.

When is Avedro's next earnings date?

Avedro is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Avedro.

What price target have analysts set for AVDR?

6 brokers have issued 12-month price objectives for Avedro's stock. Their forecasts range from $21.00 to $27.00. On average, they anticipate Avedro's stock price to reach $23.60 in the next year. This suggests a possible upside of 2.7% from the stock's current price. View Analyst Price Targets for Avedro.

What is the consensus analysts' recommendation for Avedro?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avedro in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avedro.

Has Avedro been receiving favorable news coverage?

Media headlines about AVDR stock have been trending positive on Friday, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avedro earned a coverage optimism score of 2.1 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Avedro.

Are investors shorting Avedro?

Avedro saw a drop in short interest in the month of November. As of November 15th, there was short interest totalling 133,700 shares, a drop of 19.1% from the October 31st total of 165,300 shares. Based on an average daily trading volume, of 143,600 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.3% of the shares of the stock are short sold. View Avedro's Current Options Chain.

Who are some of Avedro's key competitors?

What other stocks do shareholders of Avedro own?

Who are Avedro's key executives?

Avedro's management team includes the folowing people:
  • Dr. Reza Zadno, Pres, CEO & Director (Age 64)
  • Mr. Thomas E. Griffin, Chief Financial Officer (Age 56)
  • Dr. Rajesh K. Rajpal, Chief Medical Officer & Member of Advisory Board (Age 56)
  • Mr. James Schuermann, Chief Bus. Officer (Age 51)
  • Mr. Marc Friedman, Chief Scientific Officer

When did Avedro IPO?

(AVDR) raised $75 million in an IPO on Thursday, February 14th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Cowen, Guggenheim Securities and SVB Leerink were co-managers.

Who are Avedro's major shareholders?

Avedro's stock is owned by a number of of institutional and retail investors. Top institutional investors include Interwest Venture Management Co. (16.02%), State Street Corp (0.69%), K2 Principal Fund L.P. (0.49%), Harvest Management LLC (0.27%), Russell Investments Group Ltd. (0.25%) and Mint Tower Capital Management B.V. (0.12%). Company insiders that own Avedro stock include David First and Gilbert H Kliman. View Institutional Ownership Trends for Avedro.

Which institutional investors are selling Avedro stock?

AVDR stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Gilder Gagnon Howe & Co. LLC. View Insider Buying and Selling for Avedro.

Which institutional investors are buying Avedro stock?

AVDR stock was acquired by a variety of institutional investors in the last quarter, including K2 Principal Fund L.P., Harvest Management LLC, State Street Corp, Mint Tower Capital Management B.V., Barclays PLC, California State Teachers Retirement System and Interwest Venture Management Co.. Company insiders that have bought Avedro stock in the last two years include David First and Gilbert H Kliman. View Insider Buying and Selling for Avedro.

How do I buy shares of Avedro?

Shares of AVDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Avedro's stock price today?

One share of AVDR stock can currently be purchased for approximately $22.99.

How big of a company is Avedro?

Avedro has a market capitalization of $402.78 million and generates $27.67 million in revenue each year. The company earns $-25,120,000.00 in net income (profit) each year or ($17.97) on an earnings per share basis. Avedro employs 122 workers across the globe.View Additional Information About Avedro.

What is Avedro's official website?

The official website for Avedro is http://avedro.com/.

How can I contact Avedro?

Avedro's mailing address is 201 JONES ROAD, WALTHAM MA, 02451. The company can be reached via phone at 781-768-3400 or via email at [email protected]


MarketBeat Community Rating for Avedro (NASDAQ AVDR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Avedro and other stocks. Vote "Outperform" if you believe AVDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel